Target intelligence / Profile preview

Neuraminidase N1 (NA N1)

Target
NA N1
Molecular classification
Enzyme, Sialidase
01

Overview

Neuraminidase (NA) is a major surface glycoprotein on influenza A viruses. The N1 subtype is a class of neuraminidases present in certain strains of influenza A, such as H1N1. It functions as a sialidase, cleaving terminal sialic acid residues to facilitate the release of newly formed virions from infected cells. NA is a homotetrameric protein with each monomer consisting of approximately 470 amino acids. The active site, located in a cavity at the top of each head domain, binds Neu5Ac (sialic acid) for catalysis. NA is subject to antigenic drift, and resistance to neuraminidase inhibitors can arise through point mutations in key active site residues.

Other names
N1 NeuraminidaseInfluenza A Neuraminidase N1
02

Mechanism of action

Neuraminidase inhibitors block enzymatic activity required for viral release from host cells.

03

Biological functions

Viral releaseSialic acid cleavagePrevention of viral aggregationViral spread
04

Disease associations

InfectionInfluenza
05

Safety considerations

Drug resistance mutations (e.g., H274Y)Antigenic drift
06

Interacting drugs

Zanamivir

2 more in the full profile.

Beyond the preview

Go deeper on Neuraminidase N1 (NA N1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuraminidase N1 (NA N1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call